Bioventus finalizes employment terms for Interim CEO Anthony Bihl with $751K base salary

Bioventus Inc.

Base salary of $751,000 per year; target annual bonus of 100% of base salary.
Equity awards: options for 198,000 shares and RSUs for 76,000 shares, both vesting fully on first anniversary.
Change-in-control severance: 18 months base salary, 150% target bonus, 18 months COBRA, plus full equity acceleration.
Restrictive covenants include perpetual confidentiality, non-disparagement, and 12-month non-compete (18 months after CIC).
Agreement effective April 5, 2023; signed on April 6, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.